Navigation Links
RSB Spine, LLC Announces 2011 Revenue Growth
Date:1/4/2012

CLEVELAND, Jan. 4, 2012 /PRNewswire/ -- RSB Spine, LLC, a medical device company focused on developing unique modular spinal fusion products for surgical treatment of degenerative disc disease, today announced a 46% sales increase for 2011 versus 2010. 

Commenting on the revenue improvement, RSB Spine Chief Executive Officer John A. Redmond said: "Our performance this year was especially rewarding considering the overall spine market contraction in 2011, including the 8% decline for the fusion segment in which we compete. It is a testament to the professional execution of our master distributor, Paradigm BioDevices, and growing acceptance by surgeons of the benefits of a modular stand-alone fusion offering." 

RSB Spine is a privately held medical device company. News releases and other information on the company are available on the Internet at: www.rsbspine.com and www.paradigmbiodevices.com.


'/>"/>
SOURCE RSB Spine, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. RSB Spine, LLC, Announces Record Second-Quarter 2010 Revenue and Monthly Sales Milestone
2. RSB Spine, LLC, Announces FDA Clearance for Its InterPlate(TM) C-PS and L-PS Interbody Spacers
3. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
4. ThermoGenesis Announces Approval of AXP® by India Ministry of Health
5. Telik Announces Presentation and Webcast at 5th Annual OneMedForum Conference
6. Verify Brand™ Announces the Release of VB Enterprise 4.0
7. Sinovac Announces Resignation of Chup Hung Mok from Board of Directors
8. NeoStem Announces Participation in Multiple January Conferences
9. Bionovo Announces $5 Million Financing
10. Amsterdam Molecular Therapeutics Announces € 2.5 Million Equity Raise
11. Cord Blood America Announces Exclusive Agreement With National Childrens Leukemia Foundation to Store Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... in China , today announced that ... on February 4, 2016 a preliminary non-binding proposal letter, ... PKU V-Ming ( Shanghai ) Investment Holdings ... ( Shenzhen ) Fund Management Co., Ltd., ...
(Date:2/3/2016)... 3, 2016   ViaCyte, Inc ., a ... pluripotent stem cell-derived islet replacement therapy for the ... today announced that ViaCyte and Janssen Biotech, Inc., ... & Johnson, have agreed to consolidate the assets ... agreement provides ViaCyte with an exclusive license to ...
(Date:2/3/2016)... NEW YORK and HOLLISTON, Mass., Feb. 3, ... (Nasdaq: HART ), a biotechnology company developing ... esophagus, trachea and bronchus, today announced that CEO ... BIO CEO & Investor Conference on ... in New York City . ...
(Date:2/3/2016)... , ... February 03, 2016 , ... ... Linux and Unix visualization solutions today announced the addition of a powerful “Session ... users to see the current state of the remote Linux desktop or other ...
Breaking Biology Technology:
(Date:2/2/2016)... YORK , Feb. 2, 2016 ... of the bioinformatic market by reviewing the recent ... enabled tools that drive the field forward. Includes ... to: Identify the challenges and opportunities that ... providers and software solution developers, as well as ...
(Date:2/2/2016)... 2, 2016  Based on its recent analysis ... recognizes US-based Intelligent Retinal Imaging Systems (IRIS) with ... for New Product Innovation. IRIS, a prominent cloud-based ... America , is poised to set the ... retinopathy market. The IRIS technology presents superior price-performance ...
(Date:1/28/2016)... 2016 Synaptics (NASDAQ: SYNA ), a leading developer ... quarter ended December 31, 2015. --> ... 2016 increased 2 percent compared to the comparable quarter last year ... 2016 was $35.0 million, or $0.93 per diluted share. ... the first quarter of fiscal 2016 grew 9 percent over the ...
Breaking Biology News(10 mins):